Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union (London, United Kingdom - March 1st-2nd, 2018) - Research and Markets

Research and Markets
Posted on: 13 Dec 17

The "Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union" conference has been added to Research and Markets' offering.

This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016.

The aim of this meeting is to provide an overview of recent regulatory developments in pharmaceutical regulatory affairs in Russia and the Eurasian Union. This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016. The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will also give practical hints on the regulatory process where possible.

Who should attend?

This seminar will be of particular interest to:

  • Anyone working in pharmaceutical regulatory affairs in this region
  • Anyone interested in an update of recent developments

After attending this programme you will:

  • Understand the competitive landscape of the growing markets in CIS region
  • Discover the essential information on the new regulations and registration procedures in the Eurasian Customs Union
  • Discuss national requirements and guidance for drug approval in core CIS markets of Russia, Kazakhstan, Belarus, Ukraine and Azerbaijan
  • Develop your CIS Regional Submission Plan and place it within the global regulatory strategy
  • Gain practical advice from industry experts working in CIS region

Attending this programme will:

  • Give you the full background to the CIS pharmaceutical market
  • Ensure that you understand the full implications of the new regulations which will effect how you do business in the Eurasian Economic Union (EAEU)
  • Help clarify the document requirements and timelines of national procedures and EAEU registration procedures
  • Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries


Introduction and welcome

Russia - competitive landscape

  • Current market and projected growth
  • Pharma-2020 and Health-2020 State programmes
  • Pricing and reimbursement
  • Patent and data protection

Clinical trials in Russia and CIS

  • Russia and CIS in global clinical research
  • Clinical trial requirements
  • Local registrations trials in Russia, CIS and the Eurasian Union

Marketing authorisations in Russia

  • Regulatory authorities in Russia
  • Key regulations governing the MAA process
  • Registration procedures
  • Application dossier requirements

CIS - regional regulatory overview

  • CIS pharmaceutical market
  • CIS regional regulation co-operation - the Eurasian Union
  • CIS regulatory barriers for Market Access

Marketing authorisations in CIS

  • New Eurasian MAA procedure
  • Common regional requirements in CIS:

- administrative data

- translations


- Dossier format

- local normative documents

- samples

- labelling

Country specific requirements for MAAs:

- Ukraine, Kazakhstan, Belarus, Moldova, Georgia, Armenia, Azerbaijan, Uzbekistan, Tajikistan, Turkmenistan, Kirgizstan

Regional regulatory strategy

Workshop - CIS Regional Regulatory Strategy

Discussion will take place throughout the two days

For more information about this conference visit

View source version on

Business Wire

Last updated on: 13/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.